VSVisaSignalOfficial filing intelligence

LCA activity

Crispr Therapeutics H-1B/LCA filings

Recent labor-condition rows help reveal roles, worksites, wages, and case statuses. LCA certification is not USCIS petition approval.

View PERM

Imported LCA rows

12

Median wage

$124,379

Source period

FY2026 Q2

H-1B/LCA filing signal: As of source verification 2026-06-25, Crispr Therapeutics shows 12 imported DOL labor-condition rows through FY2026 Q2 on VisaSignal. The largest role bucket is Principal Research Associate (4 rows). The largest worksite bucket is Boston, MA (12 rows). Treat this as historical H-1B/LCA filing activity, not proof of USCIS petition approval or future sponsorship.

Wage range

Crispr Therapeutics H-1B reported wage range

Normalized from 12 imported LCA wage rows. DOL-disclosed offered and prevailing wages span different roles, worksites, and wage units — read the band as wage-distribution context, not a guaranteed offer or legal minimum.

25th percentile

$120,000

Median

$124,379

75th percentile

$144,000

Range

$102,000 – $320,000

H-1B minimum salary guideRead the DOL required-wage rule before treating an LCA salary row as a legal floor.H-1B wage levels explainedSeparate Level 1-4 prevailing-wage context from the observed salary aggregate.

H-1B evidence checklist

How to use this Crispr Therapeutics LCA evidence

For searches like "Crispr Therapeutics H-1B", "Crispr Therapeutics LCA", or "does Crispr Therapeutics sponsor H-1B", read the filing count, role/worksite pattern, and status mix together before treating the employer as a lead.

Start with the official LCA count

For "Crispr Therapeutics H-1B" or "Crispr Therapeutics LCA" research, 12 imported DOL LCA rows through FY2026 Q2 show labor-condition activity attributed to this normalized employer name. Use the count as a historical filing signal, not a hiring promise.

Read source caveats

Check role and worksite fit

Principal Research Associate (4 rows) and Boston, MA (12 rows) are the strongest role and worksite signals. Compare those row-level patterns with the wage band before treating Crispr Therapeutics as relevant to your target role or location.

Compare salary signals

Separate DOL certification from USCIS approval

Certified represents 100% of the displayed LCA rows. DOL LCA certification is not USCIS H-1B petition approval, so read the status mix with row dates and source period before treating Crispr Therapeutics as a sponsor lead. Then compare the employer against the broader H-1B sponsor database before shortlisting.

Browse H-1B sponsors

Open the row-level LCA lookup

Use the full LCA and PERM database lookup when you need to search Crispr Therapeutics rows across job titles, SOC codes, worksites, and states instead of relying only on this employer summary.

Open LCA database lookup

LCA query context

How to read Crispr Therapeutics LCA results

For searches like "Crispr Therapeutics LCA", start with the official filing count, then compare role, worksite, wage, and status signals before opening individual rows.

Role signal

Principal Research Associate is the largest imported role bucket with 4 matching rows.

Status signal

Certified is the largest observed case-status bucket, representing 100% of 12 displayed LCA rows.

Status mix is the share of displayed official DOL LCA rows by case outcome; for Crispr Therapeutics, Certified accounts for 100% of the recent LCA rows shown here as of source verification .

LCA case rows with status, decision date, role, worksite, wage, and source period
CaseStatusDecisionRoleWorksiteWageSource
I-200-26083-725330CertifiedMar 31, 2026Associate Director, Regulatory AffairsBoston, MA$195,000FY2026 Q2
I-200-26014-560041CertifiedJan 22, 2026Associate Clinical Trial ManagerBoston, MA$124,919FY2026 Q2
I-200-25350-485925CertifiedDec 23, 2025Senior Medical Director, PharmacovigilanceBoston, MA$320,000FY2026 Q1
I-200-25350-485925CertifiedDec 23, 2025Senior Medical Director, PharmacovigilanceBoston, MA$320,000FY2026 Q2
I-200-25317-405485CertifiedNov 20, 2025Senior Research Associate, Translational BiologyBoston, MA$102,000FY2026 Q2
I-200-25317-405485CertifiedNov 20, 2025Senior Research Associate, Translational BiologyBoston, MA$102,000FY2026 Q1
I-200-25273-348354CertifiedNov 7, 2025Principal Research AssociateBoston, MA$123,838FY2026 Q2
I-200-25306-356554CertifiedNov 7, 2025Principal Research AssociateBoston, MA$120,000FY2026 Q2
I-200-25306-356583CertifiedNov 7, 2025Manager, Regulatory AffairsBoston, MA$127,000FY2026 Q2
I-200-25273-348354CertifiedNov 7, 2025Principal Research AssociateBoston, MA$123,838FY2026 Q1
I-200-25306-356583CertifiedNov 7, 2025Manager, Regulatory AffairsBoston, MA$127,000FY2026 Q1
I-200-25306-356554CertifiedNov 7, 2025Principal Research AssociateBoston, MA$120,000FY2026 Q1

Related sponsors

Sponsors adjacent to Crispr Therapeutics

Employers with imported DOL LCA or PERM filings that also list Massachusetts worksites, weighted toward overlapping roles. Shared filing footprints are a research and discovery signal, not a hiring or sponsorship guarantee.

Primary source

Where this LCA filing signal comes from

LCA rows for Crispr Therapeutics are imported from DOL OFLC LCA Disclosure Data, the official US Department of Labor disclosure dataset. See About data for source caveats and Source status for import freshness, or use the LCA and PERM database lookup to search records across employers, roles, SOC codes, cities, and states. To check whether a different company sponsors H-1B, run it through the H-1B sponsor checker or review the H-1B sponsor cost guide.

DOL OFLC performance page

Date retrieved: . Last verified: . Page updated: .

FAQ

Common questions

What does Crispr Therapeutics LCA mean on VisaSignal?

The Crispr Therapeutics LCA page summarizes imported Department of Labor labor-condition rows for this normalized employer, including roles, worksites, wages, case statuses, and source periods.

Is Crispr Therapeutics LCA activity the same as H-1B approval?

No. LCA certification is an official DOL labor-condition filing signal, but USCIS decides H-1B petitions separately. Use the page as employer research context, not as an approval record.

Is Crispr Therapeutics an H-1B sponsor?

Searches like "Crispr Therapeutics H-1B" or "Crispr Therapeutics H-1B sponsor" are best read against this LCA filing activity, which reflects historical labor-condition signals at Crispr Therapeutics. It is not a promise of future sponsorship or an indicator of any individual case outcome.

Can I use this as a Crispr Therapeutics LCA lookup?

Yes. This Crispr Therapeutics LCA lookup view shows imported official DOL labor-condition rows for the employer, including job titles, worksites, wage fields, case statuses, and source periods. For a broader LCA lookup across employers, roles, SOC codes, cities, and states, use the LCA and PERM database lookup.

What H-1B salary range does Crispr Therapeutics report?

For searches like "Crispr Therapeutics H-1B salary", VisaSignal normalizes the imported LCA wage fields into a range — the 25th-to-75th-percentile band plus the lowest and highest observed values — instead of a single number. These are DOL-disclosed offered and prevailing wages spanning different roles, worksites, and wage units, so read the band as wage-distribution context, not a guaranteed offer or legal minimum.

Does an LCA certification mean an H-1B petition was approved?

No. A DOL-certified LCA is not the same as USCIS H-1B petition approval. It is an official labor-condition filing signal that should be interpreted with that limit.

Does a PERM certification mean a green card was approved?

No. PERM certification is one step in an employment-based green card process. It does not mean a green card, I-140 petition, or adjustment of status was approved.

Can this data prove an employer will sponsor a candidate?

No. Official filing history can show recent activity, roles, worksites, and wage signals, but it does not guarantee future sponsorship or predict legal outcomes.

LCA and PERM rows are filing signals, not USCIS approvals, green-card approvals, legal advice, or outcome predictions.